Management of candidiasis in the intensive care unit
- PMID: 18063602
- DOI: 10.1093/jac/dkm430
Management of candidiasis in the intensive care unit
Abstract
In the last two decades, Candida has emerged as an important opportunistic pathogen. Patients admitted to the intensive care unit (ICU) are particularly susceptible to this infection because of the severity of their underlying illness and the excess use of medical and surgical interventions. The frequent use of antibiotics, central venous catheters and other intravascular devices as well as poor gut motility or abdominal surgery place these patients at high risk of infection, which contributes to the morbidity and mortality of the already critically ill patient. Early recognition and appropriate management of invasive candidiasis are therefore important. This article addresses important management issues such as the role of screening for Candida colonization, the use of prophylaxis and the choice of antifungal agents for the treatment of presumed and proven invasive candidiasis in the adult ICU setting.
Similar articles
-
Surgical critical care: fungal infections in surgical patients.Crit Care Med. 2006 Sep;34(9 Suppl):S215-24. doi: 10.1097/01.CCM.0000231883.93001.E0. Crit Care Med. 2006. PMID: 16917426 Review.
-
Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006).Crit Care Med. 2009 May;37(5):1612-8. doi: 10.1097/CCM.0b013e31819efac0. Crit Care Med. 2009. PMID: 19325476
-
Consensus statement on the management of invasive candidiasis in Intensive Care Units in the Asia-Pacific Region.Int J Antimicrob Agents. 2009 Sep;34(3):205-9. doi: 10.1016/j.ijantimicag.2009.03.014. Epub 2009 May 5. Int J Antimicrob Agents. 2009. PMID: 19409759
-
The epidemiology of Candida colonization and invasive candidiasis in a surgical intensive care unit where fluconazole prophylaxis is utilized: follow-up to a randomized clinical trial.Ann Surg. 2009 Apr;249(4):657-65. doi: 10.1097/SLA.0b013e31819ed914. Ann Surg. 2009. PMID: 19300221 Clinical Trial.
-
Optimizing therapy for Candida infections.Semin Respir Crit Care Med. 2007 Dec;28(6):678-88. doi: 10.1055/s-2007-996415. Semin Respir Crit Care Med. 2007. PMID: 18095232 Review.
Cited by
-
COVID-19-Associated Candidiasis (CAC): An Underestimated Complication in the Absence of Immunological Predispositions?J Fungi (Basel). 2020 Oct 8;6(4):211. doi: 10.3390/jof6040211. J Fungi (Basel). 2020. PMID: 33050019 Free PMC article. Review.
-
Examination of potential virulence factors of Candida tropicalis clinical isolates from hospitalized patients.Mycopathologia. 2010 Mar;169(3):175-82. doi: 10.1007/s11046-009-9246-0. Epub 2009 Oct 23. Mycopathologia. 2010. PMID: 19851885
-
A Chitin-binding Protein Purified from Moringa oleifera Seeds Presents Anticandidal Activity by Increasing Cell Membrane Permeability and Reactive Oxygen Species Production.Front Microbiol. 2017 Jun 6;8:980. doi: 10.3389/fmicb.2017.00980. eCollection 2017. Front Microbiol. 2017. PMID: 28634471 Free PMC article.
-
Usefulness of MALDI-TOF Mass Spectrometry for Routine Identification of Candida Species in a Resource-Poor Setting.Mycopathologia. 2015 Oct;180(3-4):173-9. doi: 10.1007/s11046-015-9905-2. Epub 2015 May 28. Mycopathologia. 2015. PMID: 26016846
-
Candida albicans: A Model Organism for Studying Fungal Pathogens.ISRN Microbiol. 2012 Sep 29;2012:538694. doi: 10.5402/2012/538694. Print 2012. ISRN Microbiol. 2012. PMID: 23762753 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical